These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 8647231

  • 1. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA.
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [Abstract] [Full Text] [Related]

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Jun; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 3. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN, Scase TJ, Oberthaler KT, Craft DM, McKnight JA, Leibman NF, Charney SC, Bergman PJ.
    J Am Vet Med Assoc; 2006 Apr 01; 228(7):1053-62. PubMed ID: 16579784
    [Abstract] [Full Text] [Related]

  • 4. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H, Shimabukuro T, Wada T, Yamamoto M, Shameem IA, Otsuka T, Sakano S, Matsuyama H, Naito K, Yamamoto N.
    Hinyokika Kiyo; 1993 Aug 01; 39(8):715-20. PubMed ID: 8104387
    [Abstract] [Full Text] [Related]

  • 5. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B, Bethwaite PB, Nacey JN, Ribas JL.
    J Pathol; 1993 Aug 01; 170(4):471-7. PubMed ID: 8105046
    [Abstract] [Full Text] [Related]

  • 6. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A, Margaria E, Chiusa L.
    Am J Pathol; 1994 Aug 01; 145(2):481-9. PubMed ID: 7519830
    [Abstract] [Full Text] [Related]

  • 7. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
    Iyer VK, Raina V, Dawar R.
    Indian J Cancer; 2000 Dec 01; 37(4):140-7. PubMed ID: 12018565
    [Abstract] [Full Text] [Related]

  • 8. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC, Pong VF, Cheng CR, Wong FI, Chu RM.
    Anticancer Res; 2000 Dec 01; 20(5A):3273-80. PubMed ID: 11062753
    [Abstract] [Full Text] [Related]

  • 9. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
    Cosimi MF, Casagranda I, Porta C, Moroni M, Orsi R, Nastasi G.
    Sangre (Barc); 1992 Oct 01; 37(5):399-402. PubMed ID: 1293782
    [Abstract] [Full Text] [Related]

  • 10. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E, Rutteman GR, Kuipers-Dijkshoorn NJ, van Dierendonck JH, van Heerde P, Cornelisse CJ.
    Exp Hematol; 1993 Apr 01; 21(4):579-84. PubMed ID: 8462667
    [Abstract] [Full Text] [Related]

  • 11. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M, Clò V, Brugiatelli M, Carotenuto M, Gobbi PG, Vallisa D, Lombardo M, Avanzini P, Di Renzo N, Dini D, Baldini L, Silingardi V.
    Haematologica; 1998 Sep 15; 83(9):800-11. PubMed ID: 9825577
    [Abstract] [Full Text] [Related]

  • 13. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H.
    J Urol; 1999 Jul 15; 162(1):63-8. PubMed ID: 10379741
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Jul 15; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, Kanno S, Saito K.
    Cancer; 1998 Jan 01; 82(1):86-95. PubMed ID: 9428483
    [Abstract] [Full Text] [Related]

  • 16. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
    Mikou P, Kanavaros P, Aninos D, Tzardi M, Karameris A, Gorgoulis B, Papadopoulos N, Lavergne A, Galian A.
    Pathol Res Pract; 1993 Nov 01; 189(9):1004-9. PubMed ID: 7905623
    [Abstract] [Full Text] [Related]

  • 17. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
    Gulbahar MY, Yuksel H, Guvenc T, Okut H.
    Reprod Domest Anim; 2005 Oct 01; 40(5):468-74. PubMed ID: 16149954
    [Abstract] [Full Text] [Related]

  • 18. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E.
    Ann Acad Med Stetin; 1996 Oct 01; 42():105-22. PubMed ID: 9199116
    [Abstract] [Full Text] [Related]

  • 19. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW, van der Holt B, Mackenzie MA, Van't Veer MB, Wijermans PW, Ossenkoppele GJ, Schouten HC, Sonneveld P, Steijaert MM, Kluin PM, Kluin-Nelemans HC, Verdonck LF, Dutch-Belgian Hemato-Oncology Cooperative Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3793-801. PubMed ID: 15809447
    [Abstract] [Full Text] [Related]

  • 20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.